Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents.

To bridge the gap between long-term carcinogenicity tests and short-term screening assays such as the Ames test, several types of medium-term bioassay for rapid detection of carcinogenic agents have been developed using male F344 rats. The liver model, in which diethylnitrosamine initiation and acceleration of carcinogenesis by partial hepatectomy are essential components, requires only 8 weeks of animal experimentation and a few weeks for quantitative analysis of hepatic preneoplastic lesions. Using the model, a total of 250 chemicals have been analyzed and the efficacy of the system for hapatocarcinogens has thereby been well established. Other models are so-called multi-organ bioassays for detection of carcinogenic agents in multiple organs within relatively short periods. Among these, the DMBDD bioassay with 5 known carcinogens as initiators has been found to be most applicable and has now been introduced for practical use. Data from these bioassays and several single organ carcinogenesis systems have demonstrated that carcinogenic and modifying effects of individual exogenous agents may markedly differ from organ to organ. Therefore, research into chemoprevention should be based on a whole body level analysis. The present medium-term systems are very useful for this purpose.

[1]  T Sofuni,et al.  A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. , 1988, Mutation research.

[2]  M. Tatematsu,et al.  The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. , 1980, Gan.

[3]  M. Hirose,et al.  Effects of green tea catechins in a rat multi-organ carcinogenesis model. , 1993, Carcinogenesis.

[4]  R. Hasegawa,et al.  Carcinogenic potential of some pesticides in a medium‐term multi‐organ bioassay in rats , 1993, International journal of cancer.

[5]  M. Tatematsu,et al.  Modifying Effects of Antioxidants on Chemical Carcinogenesis , 1986, Toxicologic pathology.

[6]  M. Hirose,et al.  Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. , 1993, Carcinogenesis.

[7]  S. Fukushima,et al.  Correlation between Medium‐term Multi‐organ Carcinogenesis Bioassay Data and Long‐term Observation Results in Rats , 1993, Japanese journal of cancer research : Gann.

[8]  K. Imaida,et al.  Strategy of research for cancer--chemoprevention. , 1992, Teratogenesis, carcinogenesis, and mutagenesis.

[9]  Y. Lee,et al.  Modifying responses of allyl sulfide, indole-3-carbinol and germanium in a rat multi-organ carcinogenesis model. , 1991, Carcinogenesis.

[10]  S. Uwagawa,et al.  Enhancing Potential of 6 Different Carcinogens on Multi‐organ Tumorigenesis after Initial Treatment with N‐Methyl‐N‐nitrosourea in Rats , 1991, Japanese journal of cancer research : Gann.

[11]  S. Fukushima,et al.  Enhancing effects of diallyl sulfide on hepatocarcinogenesis and inhibitory actions of the related diallyl disulfide on colon and renal carcinogenesis in rats. , 1992, Carcinogenesis.

[12]  K. Imaida,et al.  Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver. , 1984, Gan.

[13]  S. Fukushima,et al.  Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. , 1987, Cancer research.

[14]  K. Imaida,et al.  Rapid bioassay methods for carcinogens and modifiers of hepatocarcinogenesis. , 1989, Critical reviews in toxicology.

[15]  S. Fukushima,et al.  Modifying Effects of Various Chemicals on Preneoplastic and Neoplastic Lesion Development in a Wide‐spectrum Organ Carcinogenesis Model Using F344 Rats , 1991, Japanese journal of cancer research : Gann.

[16]  S. Fukushima,et al.  Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide-spectrum organ carcinogenesis model. , 1991, Carcinogenesis.

[17]  N. Ito,et al.  Enhancement by non-mutagenic pesticides of GST-P positive hepatic foci development initiated with diethylnitrosamine in the rat. , 1993, Cancer letters.

[18]  J. Weisburger,et al.  Prevention of formation of important mutagens/carcinogens in the human food chain. , 1990, Basic life sciences.

[19]  T. Sugimura,et al.  Synergistic enhancement of small and large intestinal carcinogenesis by combined treatment of rats with five heterocyclic amines in a medium-term multi-organ bioassay. , 1994, Carcinogenesis.

[20]  S. Fukushima,et al.  Enhancing effects of sodium phenobarbital and N,N-dibutylnitrosamine on tumor development in a rat wide-spectrum organ carcinogenesis model. , 1990, Carcinogenesis.

[21]  R. Tennant,et al.  Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.

[22]  S. Fukushima,et al.  Effects of sodium nitrite and catechol, 3-methoxycatechol, or butylated hydroxyanisole in combination in a rat multiorgan carcinogenesis model. , 1993, Cancer research.

[23]  E Zeiger,et al.  Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity. , 1987, Cancer research.

[24]  S. Fukushima,et al.  Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. , 1995, Cancer research.

[25]  K. Toyoda,et al.  Inhibitory Effects of Antioxidants on N‐Bis(2‐hydroxypropyl)nitrosamine‐induced Lung Carcinogenesis in Rats , 1990, Japanese journal of cancer research : Gann.

[26]  R. Kahl.  Synthetic antioxidants: biochemical actions and interference with radiation, toxic compounds, chemical mutagens and chemical carcinogens. , 1984, Toxicology.

[27]  N. Ito,et al.  Liver medium-term bioassay in rats for screening of carcinogens and modifying factors in hepatocarcinogenesis. , 1992, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[28]  M. Tatematsu,et al.  Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. , 1985, Carcinogenesis.

[29]  K. Imaida,et al.  Effects of testosterone, dihydrotestosterone and estrogen on 3,2′‐dimethyl‐4‐aminobiphenyl‐induced rat prostate carcinogenesis , 1994, International journal of cancer.

[30]  S. Fukushima,et al.  Modification by catechol and resorcinol of upper digestive tract carcinogenesis in rats treated with methyl-N-amylnitrosamine. , 1989, Cancer research.

[31]  L W Wattenberg,et al.  Inhibition of chemical carcinogenesis. , 1978, Journal of the National Cancer Institute.

[32]  K. Ozaki,et al.  Modifying Effects of Various Chemicals on Tumor Development in a Rat Wide‐spectrum Organ Carcinogenesis Model , 1992, Japanese journal of cancer research : Gann.

[33]  D. Solt,et al.  New principle for the analysis of chemical carcinogenesis , 1976, Nature.

[34]  H. Pitot,et al.  Lack of Expression of Glutathione-S-transferase P, γ-Glutamyl Transpeptidase, and α-Fetoprotein Messenger RNAs in Liver Tumors Induced by Peroxisome Proliferators , 1988 .

[35]  N Ito,et al.  Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system. , 1988, Carcinogenesis.